EnteroMedics Changes Name to ReShape Lifesciences
EnteroMedics Inc., a Roseville-based developer of weight loss devices, announced Monday that it had formally changed its name to ReShape Lifesciences Inc.
The name change is in conjunction with the company’s recent purchase of ReShape Medical, a San Clemente, California-based obesity device maker. Additionally, the medtech company formerly known as EnteroMedics will be adopting ReShape Medical’s logo.
However, the changes don’t stop there. Shortly after announcing its purchase of ReShape Medical, EnteroMedics’ CEO informed investors the company would shift its headquarters to California and leave a “satellite office” in Minnesota.
“With the recent acquisitions of ReShape Medical, Inc. and BarioSurg, Inc., we have transformed from a single-product company to a comprehensive provider of multiple effective, innovative and minimally-invasive obesity solutions,” said Dan Gladney, president and CEO of ReShape Lifesciences, in a statement.
Gladney added that the name change exemplified the company’s “core mission of enhancing and extending life for patients.”
Currently, ReShape LifeSciences offers two FDA-approved devices: the vBloc System and ReShape Integrated Dual Balloon System. Both take different approaches to curbing hunger. The vBloc System, shaped much like a pacemaker, manipulates nerve signals to make a patient feel full, while the ReShape dual balloon device are placed within a patient’s stomach and inflated to simulate the feeling of being full.